For those new heres a look and background at how cutting edge this CDH-17 Car-T is and how respected it's 10 years in development is by the industry with a write up in Nature Cancer publication. Can you believe CHM only paid $350,000 upfront and in true Paul Hopper fashion with renumeration for the inventor and U Penn at other clinical trial and FDA milestones. Esspecially with Carl June the inventor of Car-T involved in it's development to where it is now.
Ann: Licenses viral vector technology from Penn for CDH17, page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $11.70M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.3¢ | 1.0¢ | $153.9K | 13.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 128195 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1224999 | 4 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |